Eczema News and Research RSS Feed - Eczema News and Research

Eczema or atopic dermatitis is a long-lasting, itchy inflammatory condition of the skin which may become red, dry, blistered, crusted, scaly or thickened.

Eczema can affect any part of the skin but most commonly manifests in parts of the body where skin folds are found such as the elbows or backs of the knees. The cause of eczema is not yet known but it is thought to involve an inherited tendency towards sensitive skin.

Although eczema can flare up for no apparent reason, sufferers may notice particular triggers that seem to worsen their condition. Some common examples are allergens such as pollen, house dust mites or pet fur, irritants such as detergents and soaps and rough clothing fabrics such as wool. Rarely, certain foods such as milk, eggs, wheat or nuts may trigger a flare-up.

Although eczema cannot be cured, it can be controlled by avoiding any known triggers of the condition. A range of medications are also available to help control symptoms and emollients in the form of creams, lotions, or oils can prevent dehydration of the skin and help it repair as well as relieving itchiness.

In the UK, up to 20% of children and up to 10% of adults have eczema and the condition is equally common in men and women.

Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

There have been great expectations regarding the production of a drug to block the enzyme LTA4 hydrolase, which plays a key role in the body's inflammatory response. [More]
Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS' sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO). [More]
New research identifies raised risk of self-harm among patients with certain physical illnesses

New research identifies raised risk of self-harm among patients with certain physical illnesses

New research quantifying the risk of admission to hospital for self-harm has identified a raised risk of self-harm among groups of patients with certain physical illnesses. While it is known that psychiatric illnesses are associated with a greatly elevated risk of self-harm, a moderately elevated risk was seen with common physical illnesses such as diabetes, epilepsy and asthma. [More]

Dermatologist provides tips to keep skin and hair in prime condition during winter

Winter time woes extend beyond cold temperatures and sometimes gloomy weather. Your skin can react negatively to the constant temperature changes as you move indoor to outdoor for daily living activities. [More]

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema - a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults. [More]
Low gut microbial diversity in infants' intestines can increase risk for asthma

Low gut microbial diversity in infants' intestines can increase risk for asthma

Low gut microbial diversity in the intestines of infants can increase the risk for asthma development. These are the findings of the age 7 follow-up in a multi-year study led by researchers at Linköping University in Sweden. [More]

Scientists conduct clinical trial to determine silk clothing for treatment of eczema

Three hundred children are being recruited for a clinical trial to establish whether or not specialist silk clothing really does help in the treatment of eczema. [More]
FDA, USDA approve SALMONELEX as GRAS food processing aid against Salmonella

FDA, USDA approve SALMONELEX as GRAS food processing aid against Salmonella

FDA & USDA announced today they have approved SALMONELEX as a "GRAS" (Generally Recognized as Safe) food processing aid against Salmonella. The new product consists of natural phages against Salmonella and is produced by Micreos of The Netherlands. The company confirms that industrial scale projects with US poultry processors will start in January 2014. [More]
Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions Inc.announced that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million. [More]

Early antibiotic use linked to asthma, not atopy

Research from the UK has found a “robust and dose-dependent” association between antibiotic use in the first 2 years of life and subsequent asthma at the age of 7 and a half years. [More]

Tips to relieve dry skin

Dry skin is a common problem during the winter and its effects can be painful - causing the skin to flake, itch, crack and even bleed. Yet dermatologists say there are ways people can find relief by implementing a few changes to their daily lives. [More]
Taking probiotics during pregnancy has no effect on asthma rate amoung infants

Taking probiotics during pregnancy has no effect on asthma rate amoung infants

Taking probiotics has health benefits but preventing childhood asthma isn't one of them, shows newly published research led by medical scientists at the University of Alberta. [More]
Maternal weight issues spell wheezing trouble for children

Maternal weight issues spell wheezing trouble for children

High maternal weight and gestational weight gain are independently associated with an increased risk for wheezing in preschool age children, a Dutch study has found. [More]
Childhood asthma, eczema linked to adolescent psychotic experiences

Childhood asthma, eczema linked to adolescent psychotic experiences

UK research indicates that children with asthma and eczema are significantly more likely to have psychotic experiences during adolescence, boosting a previously reported relationship between schizophrenia and atopic disorders. [More]

Childhood asthma, eczema linked to adolescent psychotic experiences

UK research indicates that children with asthma and eczema are significantly more likely to have psychotic experiences during adolescence, boosting a previously reported relationship between schizophrenia and atopic disorders. [More]

Pediatric dermatologists offer tips for treating skin ailments

As parents across the Chicago area prepare to take that perfect holiday photo to send to family and friends, they may want to consider more than just getting their kids to smile and look at the camera. [More]
Loyola dermatologist offers skin care tips for holidays

Loyola dermatologist offers skin care tips for holidays

The holidays often bring freezing temperatures, limited sleep, sugary treats and cocktails. This combination can spell trouble for your skin, according to a dermatologist at Loyola University Health System. [More]

Icahn School of Medicine receives $2.7M to investigate narrow pathway targeted immune therapy

The National Institutes of Health has awarded a research team at the Icahn School of Medicine at Mount Sinai $2.7 million to study systemic treatments for patients ​with moderate to severe atopic dermatitis (AD), also known as eczema. [More]

Doctor dispels myth related to food allergies

A person with a food allergy is more likely to be murdered than to die from a severe reaction, according to a new study. [More]

People with food allergy more likely to be murdered than to die from severe reaction

A person with a food allergy is more likely to be murdered than to die from a severe reaction, according to a new study. [More]